![Claudio Helmle](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3175697/71e3fe00-35af-4c6e-96c9-2e9590010331/profile.png)
Claudio Helmle
Europe Guide 2024
Up and Coming : Life Sciences
Email address
[email protected]Contact number
+41 58 200 35 00Share profile
Ranked in 1 Practice Areas
Up and Coming
About
Provided by Claudio Helmle
Europe
Practice Areas
• Life Sciences and Healthcare (especially pharmaceutical law, medical device law, regulatory affairs, quality management)
• General administrative law
• Antitrust and competition law
• Insurance and liability
• National and international civil procedure law
Career
• since 2022: Partner at Kellerhals Carrard
• 2012-2021: Associate at Kellerhals Carrard Berne
• 2009-2011: Internships at a district court and at a law firm
Professional Memberships
• Bernese and Swiss Bar Associations
Personal
Languages: German, English
Discover other Lawyers at
Kellerhals Carrard
Provided by Chambers
Filter by
Band
Switzerland
Corporate/M&A
![Beat Brechbühl](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3104941/ea72cb05-e1d3-41dc-a29e-06212c61e2d6/profile.png)
![Ines Pöschel](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3104967/cb2c276c-afb9-4081-b18d-c6ca8262dd98/profile.png)
![Karim Maizar](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3227254/ad163b27-b820-4d2e-ac81-1bbfb63bbd40/profile.png)
Investment Funds
![Dominik Oberholzer](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3136441/fec1f2d2-8e38-4bf5-9224-154a6f345766/profile.png)
![Armin Kuehne](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3136663/b4ef8053-4ab2-4e17-bc39-75894cd180a5/profile.png)
![Luca Bianchi](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3136653/b474bede-2937-4259-98b4-54ab52c2c655/profile.png)
Life Sciences
![Thomas Eichenberger](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3175543/8a8aef9a-3793-4170-b462-d87bde49d07b/profile.png)
![Claudio Helmle](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3175697/71e3fe00-35af-4c6e-96c9-2e9590010331/profile.png)
Restructuring/Insolvency
![Daniel Staehelin](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3179254/605f1fcb-624a-4451-8d37-88619fe1d4d7/profile.png)
![Lukas Bopp](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3179270/968e9330-deb1-4647-b1d8-3138e8688e90/profile.png)
Sport
![Jean-Pierre Morand](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3175684/574f244e-0a50-40eb-86f7-d06f8b29bda6/profile.png)
![David Casserly](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3175708/a4a4c984-5765-437c-a50e-496993ae78ce/profile.png)